Mural Oncology plc
MURANASDAQHealthcare
$2.04
+$0.00(+0.00%)
Market Cap$35382751
P/E Ratio—
52W High$4.74
52W Low$0.95
Mural Oncology plc（MURA）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MURA · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.11B | $0.16B | $0.17B | $0.16B |
| G&A Expenses | $0.03B | $0.03B | $0.02B | $0.02B |
| Total Operating Expenses | $0.13B | $0.19B | $0.18B | $0.17B |
| Operating Income | ($0.14B) | ($0.19B) | ($0.18B) | ($0.18B) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.13B) | ($0.20B) | ($0.18B) | ($0.18B) |
| Income Tax Expense | $0.00B | $0.01B | $0.00B | $0.00B |
| Net Income | ($0.13B) | ($0.21B) | ($0.19B) | ($0.18B) |
| Net Margin %(computed) | — | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-7.58 | $-12.43 | $-11.37 | $-10.51 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | ($0.13B) | ($0.19B) | ($0.18B) | ($0.17B) |
| EBITDA Margin %(computed) | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Mural Oncology plc
关于Mural Oncology plc（MURA）损益表
Mural Oncology plc（MURA）损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年，MURA实现营收$0.00B，毛利润($0.00B)（毛利率—），净利润($0.13B)（净利率—）。
常见问题
MURA · 4 问Mural Oncology plc（MURA）2024财年营收为$0.00B，同比down—%。
MURA revenueMURA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09